Increasing Prevalence of Obesity Driving Obesity/Bariatric Surgery Devices Market Growth
Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/obesity-surgery-devices-market/report-sample
According to the data released by the American Society for Metabolic and Bariatric Surgery (ASMBS), the number of bariatric surgeries carried out in the U.S. surged from 158,000 in 2011 to 196,000 in 2015. Moreover, there have been several technological advancements and innovations in the obesity surgery devices industry in recent years, owing to the rising incidence of obesity. For example, GastriSail, which is a device used in sleeve gastrectomy, was launched by Medtronic plc in June 2015. This device can also be used as a standalone device.
Make an Enquiry before Purchase: https://www.psmarketresearch.com/send-enquiry?enquiry-url=obesity-surgery-devices-market
Furthermore, the Childhood Obesity Awareness program was launched by the American Association of Physicians of Indian Origin (AAPI) in June 2013. These programs are propelling the popularity of obesity surgeries, which is, in turn, fueling the growth of the obesity/bariatric surgery devices market. Depending on procedure, the market is divided into minimally invasive and non-invasive. Sleeve gastrectomy, biliopancreatic diversion surgical procedures with a duodenal switch (BPD-DS), gastric bypass, and gastric banding are the most widely performed minimally invasive surgeries.
Hence, it can be safely said that the market will demonstrate rapid expansion in the coming years, primarily because of the rising incidence of obesity, growing public awareness about various surgical procedures that can reduce fat and cause weight loss, mushrooming population of geriatric people, and the development of technologically advanced obesity surgery devices all over the world.
About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Toll-free: +1-888-778-7886 (USA/Canada)
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Increasing Prevalence of Obesity Driving Obesity/Bariatric Surgery Devices Market Growth here
News-ID: 2483731 • Views: 504
More Releases from P&S Intelligence
Interbody Spine Implants Market Will Reach USD 2,471.8 Million By 2030 | P&S Int …
The global interbody spine implants market is experiencing growth and is projected to reach USD 2,471.8 million by 2030. This growth can be credited to the improvements in spine operation technologies, the surge in the requirement for spinal fusion devices because of the rise in the incidence of spinal syndromes, the fast acceptance of minimally invasive spine operations, and the surge in the introduction of progressive bone-grafting items. The count of
Endoscopic Retrograde Cholangiopancreatography Market Will Reach USD 2,557.7 Mil …
In 2021, the endoscopic retrograde cholangiopancreatography market was worth around USD 1,270.9 million, and it is projected to advance at an 8.1% CAGR from 2021 to 2030, hitting USD 2,557.7 million by 2030, according to P&S Intelligence. This growth can be credited to the growth in the occurrence of pancreatic cancer and a paradigm move toward minimally invasive procedures. In 2021, Endotherapy devices and endoscopes together had approximately 70% share. This
Bioprocess Validation Market To Reach USD 835 Million by 2030 | P&S Intelligence
The bioprocess validation market will advance at a compound annual rate of 9.60% by the end of this decade, to reach a value of USD 835 million by 2030. The growth of the industry is because of the increasing outsourcing of these services and the increasing stringency of the safety regulations for the healthcare sector, for maintaining compliance with good manufacturing practices. Furthermore, the rising R&D expenditure in life sciences and
Contract Research Organization Services Market To Reach USD 142.56 billion by 20 …
The contract research organization services market will advance at a compound annual growth rate of 10.4% by the end of this decade, to reach USD 142.56 billion by 2030. The development can be chiefly credited to the high cost of in-house drug growth and tech progressions in clinical trials, and these services aid in trial planning, data analysis, site access, hospital staffing, and pharmacovigilance. With older age, more ailments happen as
More Releases for Obesity
Anti-Obesity Drugs (Anti-obesity Medication) Market Will Generate Massive Revenu …
Latest survey on Anti-Obesity Drugs (Anti-obesity Medication) Market is conducted to provide hidden gems performance analysis of Anti-Obesity Drugs (Anti-obesity Medication) to better demonstrate competitive environment . The study is a mix of quantitative market stats and qualitative analytical information to uncover market size revenue breakdown by key business segments and end use applications. The report bridges the historical data from 2017 to 2022 and forecasted till 2027*, the outbreak
Covid-19 pandemic fuels pet obesity.
Covid-19 pandemic fuels pet obesity. Fit4dogsuk, is currently helping dog owners in the East Yorkshire area during the Pandemic, with the weight loss challenge for their canine companions. As we have all been forced to change our habits during Covid 19, this has also had an effect on our dog’s. Their eating habits, activity levels and weight, have all changed and this can quickly affect their quality of life. A
Fast Food and Obesity
Most of the fast food in the market contains a large quantity of sugar, #carbs and fats with a lesser quantity of vitamins and minerals. The unhealthy food ingredients in the fast food are further increased with increased portion size. The person will still consume the whole meal regardless of being completely full. People cannot stop ravishing on fast food because it is available for low cost and in close
Obesity Management Congress 2018
Obesity can be managed by combination of lifestyle change, exercise and healthy diet plans. In case of severe Obesity bariatric surgery and medications will be employed. People who have gone through bariatric surgery which have suppressed hunger and the mechanism for which causes obesity based type 2 diabetes is reversed and it also causes sixty to eighty percent weight loss for a long term. But it has it cons
Obesity Treatment Market driven by rise in childhood obesity rates
Obesity is a disorder in which excess body fat gets accumulated to such extent that it may have negative effects on health. It occurs over time when people eat more calories than they utilize. The reasons for obesity can be medical problems, inactivity, genetics, family lifestyle, unhealthy diet, medications, age, and pregnancy. Being obese increases the risk of diabetes, heart disease, stroke, arthritis, and some type of cancers. Obesity treatment
Diabetes & Obesity Drug Development Pipeline Will Continue to Grow with the Risi …
"The Report Diabetes & Obesity Drug Development Pipeline Review, 2016 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" The diabetes and obesity disease cluster is currently dominated by therapeutics indicated for type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM), and the majority of the pipeline, in terms of both quantity and quality of products, is attributable to these